ADI-PEG 20 in Combination With Gemcitabine and Docetaxel for the Treatment of Soft Tissue Sarcoma, Osteosarcoma, Ewing's Sarcoma, and Small Cell Lung Cancer
Clinical trial NCT03449901 · COMPLETED
Trial details
- NCT number
- NCT03449901
- Sponsor
- Washington University School of Medicine
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-09
- Primary completion
- 2022-07-08
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.